Home/Filings/4/0001415889-24-014103
4//SEC Filing

Dittman Jennifer 4

Accession 0001415889-24-014103

CIK 0001923840other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:36 PM ET

Size

8.8 KB

Accession

0001415889-24-014103

Insider Transaction Report

Form 4
Period: 2024-05-20
Dittman Jennifer
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2024-05-20$14.00/sh1,042$14,5880 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-05-201,04232,292 total
    Exercise: $4.30Exp: 2032-12-18Common Stock (1,042 underlying)
  • Award

    Common Stock

    2024-05-20$4.30/sh1,042$4,4811,042 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule I 0b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
  • [F2]25% of the total shares vest on December 19, 2023, and thereafter 2.08333% of the total shares uoderlying the award shall vest in equal monthly installmeots uotil fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0002022925

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:36 PM ET
Size
8.8 KB